Last reviewed · How we verify

NCT05505760: MQR

Testing Content Delivery Models for MomConnect

Status unknown NA Last updated 27 October 2023
What this trial tests

NA trial testing Quality-Based Digital Messaging in Immunization Coverage in 8,867 participants. Status unknown.

Timeline
30 May 2023
Primary endpoint
29 February 2024
29 February 2024

Quick facts

Lead sponsorIDinsight
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposehealth services research
Enrollment8,867
Start date30 May 2023
Primary completion29 February 2024
Estimated completion29 February 2024
Sites1 location across South Africa

Drugs / interventions tested

Conditions studied

Sponsor

IDinsight

Who can join

18 and older, female only, with Immunization Coverage or Breastfeeding. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The case for mobile health (mHealth) has been gaining traction as a source to improve health outcomes of individuals. mHealth refers to the use of Information and Communication Technologies (ICT) to support health care. The ubiquity and penetration of mobile phones presents the opportunity to deliver health care services directly to citizens, with the greatest potential gains in under-resourced health ecosystems. Operating for 8 years and currently supporting 1.28 million mothers through their pregnancies and early childhood care, MomConnect represents one of the largest maternal health messaging platforms in the world. Implemented at the national level, MomConnect has been credited with being the first national-scale mHealth program of its kind and has won numerous international awards. As a WhatsApp-delivered service, MomConnect has been limited by WhatsApp's historical terms of service. In its current form, MomConnect can only start a conversation with mothers once a week by alerting them of their upcoming antenatal care (ANC) appointment. Recent changes to WhatsApp's terms of service have removed the restriction around push messages for certain programs, including MomConnect. Messages have historically been restricted to weekly conversation starters and carry only generic administrative reminder-style information. As a result, it is possible that many mothers are failing to engage with the content as much as they could. If mothers were more engaged, it could greatly increase exposure and knowledge of reducing the total number of mothers exposed to critical maternal and infant health content. With the updated terms of service, there is an opportunity to test different ways of engaging mothers. This study proposes to evaluate, through a randomized controlled trial (RCT), the relative effect of three new behaviorally-informed program models on key knowledge of and adoption of healthy behaviors.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other IDinsight trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05505760.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing